Drug Metabolism Reviews

Papers
(The TQCC of Drug Metabolism Reviews is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Nano-hydroxyapatite use in dentistry: a systematic review91
Cytochrome P450 expression and regulation in the brain48
The development and hepatotoxicity of acetaminophen: reviewing over a century of progress35
Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial34
Pharmacology of apocynin: a natural acetophenone31
Drug metabolic stability in early drug discovery to develop potential lead compounds27
Toxicity mechanisms of nanoparticles in the male reproductive system23
Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions22
Pharmacokinetics and pharmacodynamics of dextromethorphan: clinical and forensic aspects21
Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease19
Pharmacogenomics in the era of next generation sequencing – from byte to bedside19
Mechanistic studies on the drug metabolism and toxicity originating from cytochromes P45018
Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids17
Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.16
Recent developments inin vitroandin vivomodels for improved translation of preclinical pharmacokinetics and pharmacodynamics data15
Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases14
The broad-spectrum antiviral recommendations for drug discovery against COVID-1914
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs13
In quest of a new therapeutic approach in COVID-19: the endocannabinoid system13
Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts13
The role of UDP-glycosyltransferases in xenobioticresistance12
Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism12
Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review11
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy11
What dominates the changeable pharmacokinetics of natural sesquiterpene lactones and diterpene lactones: a review focusing on absorption and metabolism11
Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer dru11
Janus nanoparticles: an efficient intelligent modern nanostructure for eradicating cancer11
0.01612401008606